Orchid Chemicals & Pharmaceuticals (Orchid) on Wednesday announced that it has entered into an exclusive agreement with STADA Pharmaceuticals, the US subsidiary of STADA Arzneimittel, for the development and supply of six prescription generic drug pr
'Manipur is critical to India's Look East policy.' 'It's a strategic state. In the Second World War, the Japanese entered Manipur through Burma.' 'China can use the same direction to approach India.'
The Central Drugs Standard Control Organisation has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking the number of preventives and treatments available in India to 12.
Drug Development Solutions Ltd said it is in talks with leading Indian pharmaceutical companies, including Ranbaxy and Dabur, for collaboration in drug research and it is scouting for partnership with Indian data management companies.
The central probe agency re-registered the first information report (FIR) of Goa Police on a reference from the Ministry of Home Affairs which was routed to it through the Department of Personnel and Training, officials said.
'The prisoner was admitted in the hospital due to stomach pain. The x-ray of his stomach was taken and the presence of foreign particles was visible during the examination. There is a need to investigate it thoroughly'
The ex-CM said he had the honesty to face the protesters. He said the government should hold a dialogue with locals before coming up with any project.
In his second term in office, UP Chief Minister Yogi Adityanath has retained 34 portfolios.
The latest price revision includes mostly cardiovascular drugs, anti-bacterials, anti-herpes, contraceptives and gastrointestinal medicines
This is the sixth of seven ships built under 'Project 17 Alpha' for the Navy. The first five ships of the project were launched between 2019 and 2022.
The pharma sector seeks removal of Excise Duty on Bulk drugs & Formulation of Anti-AIDS, Anti-Cancer, Anti-TB and other life-saving drugs
While the Congress is in power in Rajasthan and Chhattisgarh, Madhya Pradesh is ruled by the Bharatiya Janata Party, Telangana by the Bharat Rashtra Samithi and Mizoram by the Mizo National Front.
The Indian Council of Medical Research's national task force for COVID-19 has decided against including antiviral drug Molnupiravir in the clinical management protocol for COVID-19 as of now, official sources said on Tuesday.
Tamil Nadu Governor R N Ravi on Friday re-allocated the portfolios held by arrested state Minister V Senthil Balaji, on the recommendations of Chief Minister M K Stalin but "has not agreed" to the minister continuing in the cabinet, the Raj Bhavan said.
FDA had also issued warning letters to Ranbaxy's Paonta Sahib and Dewas facilities as it found extensive problems and deviations from manufacturing norms.
Even as the Supreme Court had recently dismissed the industry's plea against prices fixed by the regulator and its timely implementation, the National Pharmaceutical Pricing Authority has asked companies to pay the overcharged dues with 15 per cent interest.
As many as 150 applications are stuck at evaluation stage, says official.
Medicines produced in India have become a lifeline for people living in developing countries around the world.
The world's largest manufacturer of healthcare products, Johnson & Johnson, is making India a global hub of its research and development as it looks to ramp up its pharmaceutical business in the country.
The Pune-based Gennova Biopharmaceuticals has submitted phase 2 data of mRNA vaccine and has also completed the recruitment of phase 3 data.
The government on Thursday listed bills on personal data protection, to amend forest conservation laws and on the contentious ordinance on Delhi services for the monsoon session of Parliament beginning next week.
The World Health Organisation is reinstating two generic AIDS antiretroviral drugs delisted earlier this year after the Indian manufacturer carried out new studies to confirm that they are as effective as their brand-name counterparts.
The vaccine would not have production scalability issues unlike Covaxin, Bharat Biotech's COVID-19 virus vaccine.
DCGI, health ministry initiate dialogues with foreign regulators, try to understand global best practices
Sun Pharmaceutical Industries Ltd on Thursday said its Halol facility in Gujarat has been listed under import alert by the USFDA with products manufactured at the unit now are subject to refusal of admission in the US market. The development follows an inspection of the facility by the US Food and Drug Administration (USFDA) from April 26 to May 9, 2022. "We now wish to inform you that the company has received a communication from the USFDA stating that the facility has been listed under Import Alert," Sun Pharma said in a regulatory filing.
The Drugs Controller General of India has approved the manufacture of this Sars-CoV-2 spike protein recombinant nano-particle vaccine for 'examination, test, and analysis', reports Sohini Das.
Companies known for spending huge amounts on innovation globally have minuscule budgets for India. What's holding them back?
Mounting a fresh attack on the Congress, Prime Minister Narendra Modi on Friday alleged that for the sake of vote bank politics, it has nurtured, given shelter and surrendered before terror.
'For free supply of drugs and medicines itself, almost Rs 20,000 crores would be required.'
A new agreement has been clinched with pharmaceutical firms to substantially decrease the cost of treating AIDS in 66 countries in Asia, Latin America, Africa and the Caribbean, former US President Bill Clinton has announced.
Dr Reddy's Laboratories said on Thursday Novartis has decided to stop further work on an anti-diabetes compound licensed to the Swiss drug maker, the second time in six months that a foreign partner has halted development of the Indian firm's drugs.
The stock of Divis Laboratories is up 10 per cent over the last couple of trading sessions on expectations that the worst is behind and the company could see a sequential growth in the March quarter of the 2022-23 financial year (Q4FY23). The stock witnessed the highest downgrades among Nifty50 index stocks with earnings cuts over a third after the Q3FY23 results. The company had posted a 32 per cent drop in revenues over the year ago quarter in Q3FY23 and 8 per cent sequentially, which was sharply lower than Street expectations.
Dr Ajay Kumar Sood will have to complete a task his predecessor started: Getting the government to sign off on a new Science, Technology, and Innovation Policy on which work was begun in 2020.
The average expenditure of pharmaceutical companies on research and development has increased four times in the last five years.
'Countries like Israel said openly that they will hunt people down. We have no such policy.' 'We have always been following the legal process of getting them (people wanted by India) through extradition.'
On the implementation of the old pension scheme, Baghel said Rajasthan and Chhattisgarh have written to the Central government to return the people's money with the National Pension System to implement the old pension scheme, but they refused.
Under the conditions, the firms shall submit data of ongoing clinical trials and the vaccines to be supplied for programmatic setting.Adverse event following immunisation will continue to be monitored.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances